|
Hypertrophy
Citations 131-140 of 489 total displayed.
|
Past content
(since Jan 1999):
|
- Hypertension
Different Effects of Angiotensin Receptor Blockade on End-Organ Damage in Salt-Dependent and Salt-Independent Hypertension
- Karlene Maitland, LaKeesha Bridges, Wendell P. Davis, Joseph Loscalzo, and Mildred A. Pointer
Circulation 2006;114:905-911; published online before print as doi:10.1161/CIRCULATIONAHA.106.622316
[Abstract]
[Full text]
- Hypertension
Short-Term Administration of a Cell-Permeable Caveolin-1 Peptide Prevents the Development of Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy
- Jean-François Jasmin, Isabelle Mercier, Jocelyn Dupuis, Herbert B. Tanowitz, and Michael P. Lisanti
Circulation 2006;114:912-920, doi:10.1161/CIRCULATIONAHA.106.634709
[Abstract]
[Full text]
- Articles
Different Effects of Angiotensin Receptor Blockade on End-Organ Damage in Salt-Dependent and Salt-Independent Hypertension
- Karlene Maitland, LaKeesha Bridges, Wendell P. Davis, Joseph Loscalzo, and Mildred A. Pointer
Circulation published August 21, 2006, doi:10.1161/CIRCULATIONAHA.106.622316
[Abstract]
- Images in Cardiovascular Medicine
Progressive Myocardial Fibrosis in a Patient With Apical Hypertrophic Cardiomyopathy Detected by Cardiovascular Magnetic Resonance
- R. Gebker, M. Neuss, I. Paetsch, and E. Nagel
Circulation 2006;114:e75-76e, doi:10.1161/CIRCULATIONAHA.106.612994
[Full text]
- Heart Failure
Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy
- Kevin M. Harris, Paolo Spirito, Martin S. Maron, Andrey G. Zenovich, Francesco Formisano, John R. Lesser, Shannon Mackey-Bojack, Warren J. Manning, James E. Udelson, and Barry J. Maron
Circulation 2006;114:216-225; published online before print as doi:10.1161/CIRCULATIONAHA.105.583500
[Abstract]
[Full text]
- Images in Cardiovascular Medicine
Contrast Echocardiography in Apical Hypertrophic Cardiomyopathy
- Harun Otieno, Yoel Vivas, Darren Traub, Asha Raman, and Chandra Polam
Circulation 2006;114:e33-34e, doi:10.1161/CIRCULATIONAHA.105.600858
[Full text]
- Arrhythmia/Electrophysiology
Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold: The Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Trial
- Stefan H. Hohnloser, Paul Dorian, Robin Roberts, Michael Gent, Carsten W. Israel, Eric Fain, Jean Champagne, and Stuart J. Connolly
Circulation 2006;114:104-109; published online before print as doi:10.1161/CIRCULATIONAHA.106.618421
[Abstract]
[Full text]
- Articles
Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy
- Kevin M. Harris, Paolo Spirito, Martin S. Maron, Andrey G. Zenovich, Francesco Formisano, John R. Lesser, Shannon Mackey-Bojack, Warren J. Manning, James E. Udelson, and Barry J. Maron
Circulation published July 10, 2006, doi:10.1161/CIRCULATIONAHA.105.583500
[Abstract]
- Myocardial Protection and Vascular Biology
Vascular Endothelial Growth Factor Prevents Apoptosis and Preserves Contractile Function in Hypertrophied Infant Heart
- Ingeborg Friehs, Rodrigo Barillas, Nikolay V. Vasilyev, Nathalie Roy, Francis X. McGowan, and Pedro J. del Nido
Circulation 2006;114:I-290-295I-, doi:10.1161/CIRCULATIONAHA.105.001289
[Abstract]
[Full text]
- Articles
Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold. The Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Trial
- Stefan H. Hohnloser, Paul Dorian, Robin Roberts, Michael Gent, Carsten W. Israel, Eric Fain, Jean Champagne, and Stuart J. Connolly
Circulation published July 3, 2006, doi:10.1161/CIRCULATIONAHA.106.618421
[Abstract]
|
|
